Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma

Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma

Patrick Martin, Alisa Cohen, Sharif Uddin, Laura Epelbaum, Serene Josiah Shire, A Takeda Company, Lexington, MA, USACorrespondence: Patrick Martin Email ptmartin@alum.mit.eduPurpose: TAK-639 is a topical, nine-amino acid, synthetic, C-type natriuretic peptide analog in Phase 1 development for the tr...

Full description

Bibliographic Details
Main Authors: Martin P, Cohen A, Uddin S, Epelbaum L, Josiah S
Format: Article
Language:English
Published: Dove Medical Press 2020-03-01
Series:Clinical Ophthalmology
Subjects:
glaucoma
intraocular pressure
ocular hypertension
shp-639
tak-639
Online Access:https://www.dovepress.com/randomized-double-masked-placebo-controlled-dose-escalation-study-of-t-peer-reviewed-article-OPTH

Internet

https://www.dovepress.com/randomized-double-masked-placebo-controlled-dose-escalation-study-of-t-peer-reviewed-article-OPTH

Similar Items